---
title: "Orient Biotech and its subsidiaries have obtained multiple medical device registration certificates"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/253410925.md"
description: "Orient Biotech and its wholly-owned subsidiary, American Hengjian and Shanghai Wanzi Health Biotechnology, recently obtained multiple medical device registration certificates, including the Influenza A/B Virus Antigen Detection Kit, Anti-MPO Antibody Detection Kit, Anti-PR3 Antibody Detection Kit, Anti-GBM Antibody Detection Kit, Healgen® Immunofluorescence Analyzer (OG-H180), and Healgen® AccuFluor Fentanyl Fluorescence Immunoassay Test Kit"
datetime: "2025-08-18T07:43:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/253410925.md)
  - [en](https://longbridge.com/en/news/253410925.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/253410925.md)
---

# Orient Biotech and its subsidiaries have obtained multiple medical device registration certificates

According to the Zhitong Finance APP, Orient Biotech (688298.SH) announced that the company and its wholly-owned subsidiary, American Hengjian and Shanghai Wanzi Health Bio, have recently obtained the following medical device registration certificates. The product names are: Influenza A/B Virus Antigen Detection Kit (Colloidal Gold Method) (Professional), Anti-MPO Antibody, Anti-PR3 Antibody, Anti-GBM Antibody Detection Kit (Flow Fluorescence Luminescence Method), Healgen® Immunofluorescence Analyzer (OG-H180), and Healgen® AccuFluor Fentanyl Fluorescence Immunoassay (FIA) Test Kit - Qualitative

### Related Stocks

- [688298.CN](https://longbridge.com/en/quote/688298.CN.md)

## Related News & Research

- [12:00 ETVilla Albertine Announces the Lafayette Fellowship, a Prestigious New Graduate Scholarship in France for America's Emerging Leaders](https://longbridge.com/en/news/287248753.md)
- [11:05 ETThe Church of Jesus Christ of Latter-day Saints Commits $25 Million to the UNICEF-led Child Nutrition Fund](https://longbridge.com/en/news/287088476.md)
- [14:47 ET6th Annual Midwest Design Awards Entry Period Now Open](https://longbridge.com/en/news/286808240.md)
- [4Sight expects FY earnings per share up 29.3%-40.1%](https://longbridge.com/en/news/287226173.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)